Australia markets closed

T2 Biosystems, Inc. (TTOO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.3400+0.0100 (+0.75%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5198.25M
Enterprise value 3211.78M
Trailing P/E N/A
Forward P/E 1-5.36
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)20.14
Price/book (mrq)N/A
Enterprise value/revenue 321.52
Enterprise value/EBITDA 6-4.81

Trading information

Stock price history

Beta (5Y monthly) 1.05
52-week change 3-54.42%
S&P500 52-week change 36.23%
52-week high 33.1500
52-week low 30.2350
50-day moving average 31.3019
200-day moving average 31.2303

Share statistics

Avg vol (3-month) 36.35M
Avg vol (10-day) 33.82M
Shares outstanding 5147.95M
Float 140.66M
% held by insiders 15.94%
% held by institutions 19.38%
Shares short (14 Oct 2020) 413.4M
Short ratio (14 Oct 2020) 45.01
Short % of float (14 Oct 2020) 49.50%
Short % of shares outstanding (14 Oct 2020) 49.05%
Shares short (prior month 14 Sep 2020) 412.55M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Jun 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)-466.88%

Management effectiveness

Return on assets (ttm)-58.09%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)9.84M
Revenue per share (ttm)0.14
Quarterly revenue growth (yoy)41.50%
Gross profit (ttm)-24.75M
EBITDA -44.02M
Net income avi to common (ttm)-53.85M
Diluted EPS (ttm)-0.7630
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)35.8M
Total cash per share (mrq)0.24
Total debt (mrq)49.33M
Total debt/equity (mrq)N/A
Current ratio (mrq)5.96
Book value per share (mrq)-0.03

Cash flow statement

Operating cash flow (ttm)-51.88M
Levered free cash flow (ttm)-37.63M